I am pleased to announce that John Monica will be speaking on "The Possible Adverse Consequences of Pre-emptive Nanotechnology Regulation" at the two-day conference and workshop, Regulations for Nanotechnology in Consumer Products, February 8-9, 2007, Washington Marriott, Washington, D.C.  This conference is aimed at those interested in doing more than simply scratching the surface of nanotechnology regulatory concerns.  A copy of the preliminary agenda can be found here.

Speakers will include:

  • Dr. Linda Katz, M.P.H., Director, Office of Cosmetics and Colors, FDA, US
  • David Rejeski, Director, Project on Emerging Nanotechnologies, Woodrow Wilson International Center for Scholars, US
  • Dr. Peter Hatto, Chairman International Standards Committee (ISO)TC229 Nanotechnologies, Director of Research, UK
  • Dr. Christoph Meili, CEO, THE INNOVATION SOCIETY, Switzerland
  • Christopher Murray, Manager, Nanoscale Materials and Devices, IBM, US
  • Ruben Serrato, Managing Editor, NANOTECHNOLOGY LAW & BUSINESS and Venture Partner, TEL VENTURE CAPITAL, US
  • Dr. Kristen M Kulinowski, Executive Director for Education and Public Policy, Center for Biological and Environmental Nanotechnology, Director, International Council on Nanotechnology (ICON), Rice University, US
  • Dr. Brent Segal, Co-Founder and CEO, NANTERO, US
  • Dr. Sandy Weinberg, VP Regulations, Tikvah Therapeutics, US
  • Dr. Justin Teeguarden, Senior Research Scientist, PACIFIC NORTHWEST NATIONAL LABORATORY, US
  • Alan Gotcher, CEO, ALTAIRNANO, US
  • Matt Hull, Principal Investigator, LUNA INNOVATIONS INC, US
  • Dr. Annette Santamaria, Senior Manager, ENVlRON INTERNATIONAL CORPORATION, US
  • Alissa Havens, Communications Director, DITTUS COMMUNICATIONS, US